Bone marrow transplantation in beta-thalassemia major with prevention of graft-vs-host disease
Slavin, S.; Or, R.; Cividalli, G.; Brautbar, C.; Hale, G.; Waldmann, H.; Rachmilewitz, E.
Birth Defects Original Article Series 23(5b): 313-316
1988
ISSN/ISBN: 0547-6844 PMID: 3291967 Document Number: 306147
Document emailed within 1 workday
Related Documents
Chowdhury, N.C.; Jin, M.X.; Hardy, M.A.; Oluwole, S.F. 1993: Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells Transplantation Proceedings 25(1 Pt 1): 475-476de Witte, T.; Janssen, J.; de Pauw, B.; Holdrinet, R.; Wessels, J.; Haanen, C. 1986: Prevention of graft-vs-host disease following allogeneic bone marrow transplantation Nederlands Tijdschrift Voor Geneeskunde 130(28): 1290-1291
Devergie, A.; Esperou, H.; Traineau, R.; Varrin, F.; Lehn, P.; Gluckman, E. 1989: Role of immunosuppressive drugs for prevention of graft-v-host disease after bone marrow transplantation Nouvelle Revue Francaise d'Hematologie 31(2): 73-75
Cooper, M.H.; Markus, P.M.; Cai, X.; Starzl, T.E.; Fung, J.J. 1991: Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506 Transplantation Proceedings 23(6): 3238-3239
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Champlin, R.; Jansen, J.; Ho, W.; Gajewski, J.; Nimer, S.; Lee, K.; Territo, M.; Winston, D.; Tricot, G.; Reichert, T. 1991: Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia Transplantation Proceedings 23(1 Pt 2): 1695-1696
Oluwole, S.F.; Engelstad, K.; Hardy, M.A. 1992: Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum Transplantation Proceedings 24(6): 2858-2859
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Sakamoto, K.; Sachs, D.H.; Shimada, S.; Popitz-Bergez, F.A.; Pennington, L.R.; Pescovitz, M.D.; McDonough, M.A.; MacVittie, T.J.; Katz, S.I.; Gress, R.E. 1988: Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow Transplantation 45(5): 869-875
Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Li, V.; Molina, L.; Michallet, M.; Hostein, J. 1992: Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion Gastroenterologie Clinique et Biologique 16(1): 29-36
Izzi, T.; Lucarelli, G. 1983: Bone marrow transplantation in humans. IV. the graft versus host disease Recenti Progressi in Medicina 74(6): 720-732
Jeannet, M.; Vaucher, A.; Gervasoni, C. 1972: Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation Schweizerische Medizinische Wochenschrift 102(44): 1598-1600
Cooper, M.H.; Hartman, G.G.; Starzl, T.E.; Fung, J.J. 1991: The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506 Transplantation Proceedings 23(6): 3234-3235
Champlin, R. 1992: Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation Seminars in Hematology 29(3 Suppl 2): 46-52
Phillips, G.L.; Nevill, T.J.; Spinelli, J.J.; Nantel, S.H.; Klingemann, H.G.; Barnett, M.J.; Shepherd, J.D.; Chan, K.W.; Meharchand, J.M.; Sutherland, H.J. 1995: Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation Bone Marrow Transplantation 15(2): 213-219
Sullivan, K.M.; Siadak, M.F.; Witherspoon, R.P. 1990: Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation Transplantation Proceedings 22(3): 1336-1338
Johnsen, H.E. 1993: Predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings New England Journal of Medicine 328(20): 1497-1498
Lachance, S.; Le Gouvello, S.; Roudot, F.; Kuentz, M.; Bernaudin, F.; Beaujean, F.; Bierling, P.; Cordonnier, C.; Farcet, J.P.; Vernant, J.P. 1997: Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies Transplantation 64(8): 1147-1152